BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Saturday, May 4, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 22, 2004
View Archived Issues
atugen and Aventis collaborate in identifying siRNA compounds
Read More
Medarex and diaDexus expand collaboration into cancer antibody therapeutics
Read More
Update on Sinovac's split flu vaccine
Read More
Second performance milestone in Lexicon/Genentech drug discovery alliance
Read More
Vernalis and Novartis complete Hsp90 license agreement
Read More
Sumitomo licenses Japanese rights to repaglinide
Read More
Update on Endo's oxymorphone program
Read More
Metabolic completes dosing in AOD-9604 phase IIb trial
Read More
Two series of HDAC inhibitors presented by Roche researchers
Read More
New vanilloid VR1 ligands for pain and ulcerative colitis
Read More
Pfizer scientists describe new cannabinoid CB1 antagonists
Read More
Novel cytochrome b5 inhibitors and their use in sickle cell disease
Read More
New methionyl-tRNA synthetase inhibitors claimed by Replidyne
Read More
Predix patent covers 5-HT1A receptor modulators for anxiety, ADD and sexual dysfunction
Read More
Novel CDK4 inhibitors in early development at Roche
Read More
Novel gamma-secretase inhibitors prepared and tested at Roche
Read More
Medarex and Pfizer form global collaboration to create fully human antibody products
Read More
ML Laboratories licenses rights to budesonide Clickhaler
Read More
Potent antiviral agent brings new insight into enterovirus 71 drug-resistance mechanism
Read More
Small-molecule inhibitor of beta-catenin/cyclic AMP effective in models of colon cancer
Read More
Prous Science announces publication of a comprehensive review on narcolepsy
Read More
Novel somatostatin analogue shows analgesic effects in vivo
Read More
Oncology collaboration between Ablynx and Genencor
Read More
Oxford BioMedica extends agreement for cytochrome P450 enzymes
Read More
Last volunteers to be enrolled in phase I HIV vaccine trial
Read More
Acambis to submit BLA for ACAM-2000 smallpox vaccine after removal of FDA's clinical hold on trials
Read More
U.S. Army to evaluate Pharming's recombinant human fibrinogen product
Read More
hBNP formulation affects arterial pressure in dogs
Read More
Serotonin receptor a possible target for allergic disease treatment
Read More
Fibromyalgia patients benefit from duloxetine treatment
Read More
3-Aminobenzamide offers neuroprotection in stroke model
Read More
PPARgamma chemoprotective for mammary, ovarian and skin cancers
Read More
BAY-58-2667 plus BNP beneficial in CHF model
Read More
Millennium reports development pipeline and marketed product progress
Read More
Xenova tracks progress of key programs in year to date
Read More